Intraoperative radiotherapy for brain metastases: first-stage results of a single-arm, open-label, phase 2 trial

被引：0
|
作者：
Douglas Guedes de Castro
Paulo Issamu Sanematsu
Antônio Cassio Assis Pellizzon
Sérgio Hideki Suzuki
Ricardo Cesar Fogaroli
José Eduardo Souza Dias
Guilherme Rocha Melo Gondim
Daniel Alvarez Estrada
Maria Letícia Gobo Silva
Marcio Saquy Rassi
Michael Jenwei Chen
Richard Giacomelli
Henderson Ramos
Elson Santos Neto
Carolina Humeres Abrahão
Tharcisio Machado Coelho
Liao Shin Yu
Cassio de Queiroz Tannous
Vinicius Fernando Calsavara
Frank Anton Giordano
Jean Gonçalves de Oliveira
机构：
[1] A.C. Camargo Cancer Center,Department of Radiation Oncology
[2] A.C. Camargo Cancer Center,Department of Neurosurgery
[3] A.C. Camargo Cancer Center,Department of Imaging
[4] Cedars-Sinai Medical Center,Samuel Oschin Comprehensive Cancer Institute
[5] Heidelberg University,Department of Radiation Oncology, DKFZ
[6] Santa Casa de São Paulo School of Medical Sciences,Hector Cancer Institute, Medical Faculty Mannheim
来源：
Journal of Neuro-Oncology | 2023年 / 162卷
关键词：
Brain metastases; Neurosurgery; Radiotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：211 / 215
页数：4
相关论文
共 50 条
  • [31] Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study
    LANCET ONCOLOGY, 2023, 24 (04): : E145 - E145
  • [32] Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial
    Calabro, Luana
    Morra, Aldo
    Fonsatti, Ester
    Cutaia, Ornella
    Amato, Giovanni
    Giannarelli, Diana
    Di Giacomo, Anna Maria
    Danielli, Riccardo
    Altomonte, Maresa
    Mutti, Luciano
    Maio, Michele
    LANCET ONCOLOGY, 2013, 14 (11): : 1104 - 1111
  • [33] A single-arm, multicenter, open-label phase 2 trial of surufatinib in patients with unresectable or metastatic biliary tract cancer
    Xu, Jianming
    Bai, Yuxian
    Sun, Huichuan
    Bai, Chunmei
    Jia, Ru
    Li, Yi
    Zhang, Wenjie
    Liu, Lei
    Huang, Cheng
    Guan, Mei
    Zhou, Jinghong
    Su, Weiguo
    CANCER, 2021, 127 (21) : 3975 - 3984
  • [34] Camrelizumab plus apatinib for previously treated advanced adrenocortical carcinoma: A single-arm, open-label, phase 2 trial
    Wei, Zhigong
    Zhu, Yuchun
    Cai, Lei
    Peng, Xingchen
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [35] Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis
    Thompson, Richard J.
    Artan, Reha
    Baumann, Ulrich
    Calvo, Pier Luigi
    Czubkowski, Piotr
    Dalgic, Buket
    D'Antiga, Lorenzo
    Di Giorgio, Angelo
    Durmaz, Ozlem
    Gonzales, Emmanuel
    Grammatikopoulos, Tassos
    Gupte, Girish
    Hardikar, Winita
    Houwen, Roderick H. J.
    Kamath, Binita M.
    Karpen, Saul J.
    Lacaille, Florence
    Lachaux, Alain
    Lainka, Elke
    Loomes, Kathleen M.
    Mack, Cara L.
    Mattsson, Jan P.
    Mckiernan, Patrick
    Ni, Quanhong
    Ozen, Hasan
    Rajwal, Sanjay R.
    Roquelaure, Bertrand
    Shteyer, Eyal
    Sokal, Etienne
    Sokol, Ronald J.
    Soufi, Nisreen
    Sturm, Ekkehard
    Tessier, Mary Elizabeth
    van der Woerd, Wendy L.
    Verkade, Henkjan J.
    Vittorio, Jennifer M.
    Wallefors, Terese
    Warholic, Natalie
    Yu, Qifeng
    Horn, Patrick
    Kjems, Lise
    JHEP REPORTS, 2023, 5 (08)
  • [36] Axitinib in first-line for patients with metastatic papillary renal cell carcinoma: Results of the multicentre, open-label, single-arm, phase II AXIPAP trial
    Negrier, Sylvie
    Rioux-Leclercq, Nathalie
    Ferlay, Celine
    Gross-Goupil, Marine
    Gravis, Gwenaelle
    Geoffrois, Lionel
    Chevreau, Christine
    Boyle, Helen
    Rolland, Frederic
    Blanc, Ellen
    Ravaud, Alain
    Dermeche, Slimane
    Flechon, Aude
    Albiges, Laurence
    Perol, David
    Escudier, Bernard
    EUROPEAN JOURNAL OF CANCER, 2020, 129 : 107 - 116
  • [37] Efficacy and safety of minocycline in retinitis pigmentosa: a prospective, open-label, single-arm trial
    Chen, Yuxi
    Pan, Yuan
    Xie, Yanyan
    Shi, Yuxun
    Lu, Yao
    Xia, Yiwen
    Su, Wenru
    Chen, Xiaoqing
    Li, Zuoyi
    Wang, Minzhen
    Miao, Siyu
    Yang, Yating
    Jin, Chenjin
    Luo, Guangwei
    Long, Shixian
    Xiao, Hui
    Huang, Chuangxin
    Zhang, Jian
    Liang, Dan
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [38] Camrelizumab plus concurrent chemoradiotherapy for locally advanced cervical cancer: Preliminary results of a single-arm, open-label, phase II trial
    Xiao, Y.
    Cheng, H.
    Wang, L.
    Yang, L.
    Yu, X.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S805 - S805
  • [39] Surufatinib plus toripalimab in patients with advanced solid tumors: a single-arm, open-label, phase 1 trial
    Cao, Yanshuo
    Lu, Ming
    Sun, Yu
    Gong, Jifang
    Li, Jie
    Lu, Zhihao
    Li, Jian
    Zhang, Xiaotian
    Li, Yan
    Peng, Zhi
    Zhou, Jun
    Wang, Xicheng
    Shen, Lin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (02) : 779 - 789
  • [40] A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer
    Hasegawa, Hirotaka
    Shitara, Kohei
    Takiguchi, Shuji
    Takiguchi, Noriaki
    Ito, Seiji
    Kochi, Mitsugu
    Horinouchi, Hidehito
    Kinoshita, Takahiro
    Yoshikawa, Takaki
    Muro, Kei
    Nishikawa, Hiroyoshi
    Suna, Hideaki
    Kodera, Yasuhiro
    GASTRIC CANCER, 2022, 25 (03) : 619 - 628
12345